Berkeley Lights, Inc.
5858 Horton Street
Suite 320
Emeryville
California
94608
United States
86 articles about Berkeley Lights, Inc.
-
Berkeley Lights Opens Shanghai Location
9/5/2019
Berkeley Lights, Inc. announced the opening of a representative office in Pudong, Shanghai.
-
BioSpace Movers and Shakers, Aug. 9
8/9/2019
Biopharma companies strengthen their senior leadership teams and boards of directors. -
Berkeley Lights to Launch New T Cell Functional Analytics Platform at the 34ᵗʰ Congress of the International Society for Advancement of Cytometry (CYTO)
6/18/2019
Berkeley Lights, Inc. announced the launch of the LightningTM optofluidic platform, which directly visualizes phenotype and function of 1000s of T cells in days to help scientists address challenges in developing cancer immunotherapies.
-
Abveris Deploys the Berkeley Lights Beacon® Platform for Antibody Discovery
6/17/2019
Abveris will be launching a sister company, AbX Biologics, with an exclusive focus on therapeutic antibody discovery services.
-
Berkeley Lights Selected as One of the World's Most Innovative Companies of 2019 by Fast Company
2/20/2019
Berkeley Lights, Inc., a leader in digital cell biology, announced that it has been named one of Fast Company's 2019 Most Innovative Companies in Biotech.
-
Berkeley Lights calls itself a digital cell biology company. It develops and markets tech platforms for what it calls “the intersection of biology, technology and information.”
-
Movers and Shakers for Sept. 4
9/4/2018
Biopharm companies closed out August with a plethora of changes to executive and senior leadership positions. Let's take a look. -
Shire Adopts Berkeley Lights' Beacon OptoFluidic Platform to Speed Cell Line Development
1/30/2018
Shire's decision was based on a study that compared their existing CLD workflow to a workflow using the Beacon.
-
Another Large Pharma Implements Berkeley Lights' Beacon OptoFluidic Platform for Accelerating Antibody Discovery
1/16/2018
Berkeley Lights announced today that Novartis is implementing BLI's Beacon platform to help accelerate their antibody discovery workflow.
-
Berkeley Lights Announces Research Collaboration and License Agreement With Pfizer
1/4/2018
Through the collaboration, the companies will combine BLI's platform - which utilizes a light-based, nano-fluidic method to select, characterize, culture and export single cells - with Pfizer's expertise in gene editing, sequencing, and molecular biology, as well as B-cell screening, to help advance the research aims and influence the development of the Beacon platform.
-
Daiichi Sankyo Working with Berkeley Lights' Beacon OptoFluidic Platform for Cell Line Development
10/30/2017
Berkeley Lights announced today a program with Daiichi Sankyo focused on using the Beacon platform to accelerate its cell line development workflow.
-
Berkeley Lights Selects Tekon As Partner To Expand Into Chinese Market
10/3/2017
-
Berkeley Lights Automates Biological Processing To Reduce Drug Development Timelines And Bring Therapies To Market Faster
9/12/2017
-
Berkeley Lights Announces Strategic Project With Bayer Focused On Cell Line Development And Antibody Discovery
9/12/2017
-
Berkeley Lights Announces Cell Line Development Program
6/27/2017
-
Berkeley Lights Announces GlaxoSmithKline Adoption Of The Beacon OptoFluidic Platform
6/13/2017
-
Berkeley Lights Announces Expanded Adoption Of The Beacon Opto-Fluidic Platform
5/15/2017
-
Berkeley Lights Announces CEO Transition As Part Of Succession Planning
3/6/2017
-
Berkeley Lights And Mount Sinai School of Medicine Expand Relationship
2/2/2017
-
Berkeley Lights Announces Collaboration Agreement With Roche
11/1/2016